NIPENT Side Effects

7021574-0 | Marrow Hyperplasia, Myelodysplastic Syndrome
on Sep 17, 2010 Female patient from UNITED STATES , 62 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Nipent (View Usage). Patient experienced the following unwanted or unexpected effects: marrow hyperplasia, myelodysplastic syndrome. Nipent dosage: 9.0 Mg Cumulative Dose. During the same period patient was treated with RITUXAN (1820 Mg Cumulative Dose) (View Rituxan Review and Rituxan Label ), CYCLOPHOSPHAMIDE (1400.0 Mg Cumulative Dose) (View Cyclophosphamide Review and Cyclophosphamide Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ), (ALKYLATING AGENTS) (View (alkylating Agents) Review and (alkylating Agents) Label ).

7003617-3 | Acute Pulmonary Oedema, Electromechanical Dissociation, Oxygen Saturation Decreased, Tachypnoea
Patient was taking Nipent (View Usage). Patient had the following side effects: acute pulmonary oedema, electromechanical dissociation, oxygen saturation decreased, tachypnoea on Sep 14, 2010 from UNITED STATES Additional patient health information: Female patient , 60 years of age, weighting 200.0 lb, was diagnosed with chronic lymphocytic leukaemia and. Nipent dosage: 8 Mg, Total Dose Administered This Course. During the same period patient was treated with CYCLOPHOSPHAMIDE (1200 Mg, Total Dose Administered This Coarse) (View Cyclophosphamide Review and Cyclophosphamide Label ), RITUXIMAB (750 Mg, Total Dose Administered This Course) (View Rituximab Review and Rituximab Label ). Patient was hospitalized.

7001568-1 | Acute Pulmonary Oedema, Electromechanical Dissociation, Oxygen Saturation Decreased, Respiratory Disorder
Adverse event was reported on Sep 07, 2010 by a Female patient taking Nipent (View Usage) (Dosage: 8 Mg, Total Dose Administered This Course) was diagnosed with chronic lymphocytic leukaemia and. Location: UNITED STATES , 60 years of age, weighting 200.0 lb, After Nipent was administered, patient had the following side effects: acute pulmonary oedema, electromechanical dissociation, oxygen saturation decreased, respiratory disorder. During the same period patient was treated with CYCLOPHOSPHAMIDE (1200 Mg, Total Dose Administered This Course) (View Cyclophosphamide Review and Cyclophosphamide Label ), RITUXIMAB (750 Mg, Total Dose Administered This Course) (View Rituximab Review and Rituximab Label ). Patient was hospitalized.

6109164-5 | Dyspnoea, Toxic Skin Eruption
on Feb 23, 2009 Male patient from FRANCE , 52 years of age, was diagnosed with hairy cell leukaemia, antifungal prophylaxis and was treated with Nipent (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, toxic skin eruption. Nipent dosage: 8 Mg, 1 Every 15 Days, Intravenous. During the same period patient was treated with BACTRIM (80 Mg, Daily, Oral) (View Bactrim Review and Bactrim Label ). Patient was hospitalized.


6036487-0 | Acute Coronary Syndrome, Disease Progression, Ventricular Fibrillation
on Jun 17, 2008 Female patient from FRANCE , 79 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Nipent (View Usage). Patient had the following side effects: acute coronary syndrome, disease progression, ventricular fibrillation. Nipent dosage: . During the same period patient was treated with (MABTHERA) (View (mabthera) Review and (mabthera) Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ). Patient was hospitalized.

5928835-4 | Fatigue, Lethargy, Nervous System Disorder, Optic Neuropathy, Sensory Disturbance
Patient was taking Nipent (View Usage). After Nipent was administered, patient had the following side effects: fatigue, lethargy, nervous system disorder, optic neuropathy, sensory disturbance on Oct 08, 2008 from UNITED KINGDOM Additional patient health information: Female patient , 47 years of age, was diagnosed with graft versus host disease and. Nipent dosage: 7.2 Mg Fortnightly Iv. During the same period patient was treated with MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), VALACYCLOVIR HCL (View Valacyclovir Hcl Review and Valacyclovir Hcl Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ), PENICILINA V (View Penicilina V Review and Penicilina V Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized and became disabled.

5909152-5 | Lethargy
Adverse event was reported on Sep 16, 2008 by a Female patient taking Nipent (View Usage) (Dosage: ) was diagnosed with graft versus host disease and. Location: UNITED KINGDOM , 47 years of age, Patient experienced the following unwanted or unexpected effects: lethargy.

5858929-3 | Acute Respiratory Distress Syndrome, Asthenia, Blood Pressure Systolic Decreased, Cardiomegaly, Chronic Lymphocytic Leukaemia, Confusional State, Cough, Diarrhoea, Disease Progression
on Aug 12, 2008 Male patient from UNITED STATES , 67 years of age, weighting 215.2 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Nipent (View Usage). Patient had the following side effects: acute respiratory distress syndrome, asthenia, blood pressure systolic decreased, cardiomegaly, chronic lymphocytic leukaemia, confusional state, cough, diarrhoea, disease progression. Nipent dosage: 4 Mg/m2. During the same period patient was treated with RITUXIMAB (375 Mg/m2) (View Rituximab Review and Rituximab Label ), CYCLOPHOSPHAMIDE (600 Mg/m2) (View Cyclophosphamide Review and Cyclophosphamide Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ). Patient was hospitalized.

5835413-4 | Anaemia, Cholecystitis, Clostridium Difficile Colitis, Rash Pruritic
on Jul 29, 2008 Female patient from UNITED STATES , 68 years of age, weighting 172.0 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Nipent (View Usage). After Nipent was administered, patient had the following side effects: anaemia, cholecystitis, clostridium difficile colitis, rash pruritic. Nipent dosage: 7 Mg Q21days Iv. During the same period patient was treated with CYTOXAN (View Cytoxan Review and Cytoxan Label ), IMMUNE GLOBULIN INTRAVENOUS (HUMAN) (View Immune Globulin Intravenous (human) Review and Immune Globulin Intravenous (human) Label ). Patient was hospitalized.

5798138-X | Atypical Mycobacterial Infection
Patient was taking Nipent (View Usage). Patient experienced the following unwanted or unexpected effects: atypical mycobacterial infection on Jun 12, 2008 from FRANCE Additional patient health information: Male patient , 55 years of age, was diagnosed with leukaemia and. Nipent dosage: . During the same period patient was treated with VALACYCLOVIR HCL (View Valacyclovir Hcl Review and Valacyclovir Hcl Label ), TRIFLUCAN (View Triflucan Review and Triflucan Label ), ZOPHREN (View Zophren Review and Zophren Label ), STABLON (View Stablon Review and Stablon Label ), BACTRIM (View Bactrim Review and Bactrim Label ). Patient was hospitalized.

5678692-9 | Abdominal Pain Lower, Bone Marrow Failure, Diverticulitis, Hepatic Cyst, Hypercoagulation, Immunosuppression, Pyuria
Adverse event was reported on Mar 14, 2008 by a Male patient taking Nipent (View Usage) (Dosage: 8.5 Mg Q3w Iv) was diagnosed with chronic lymphocytic leukaemia and. Location: UNITED STATES , 45 years of age, weighting 206.0 lb, Patient had the following side effects: abdominal pain lower, bone marrow failure, diverticulitis, hepatic cyst, hypercoagulation, immunosuppression, pyuria. During the same period patient was treated with CYTOXAN (1280 Mg Q3w Iv) (View Cytoxan Review and Cytoxan Label ), RITUXAN (800 Mg Q3w Iv) (View Rituxan Review and Rituxan Label ), MEPRON (View Mepron Review and Mepron Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), COUMADIN. MFR: NOT SPECIFIED (View Coumadin. Mfr: Not Specified Review and Coumadin. Mfr: Not Specified Label ), L LYSINE (View L-lysine Review and L-lysine Label ), NEBUPENT (View Nebupent Review and Nebupent Label ). Patient was hospitalized.

5613734-8 | Blepharitis, Blood Bicarbonate Increased, Blood Chloride Increased, Blood Creatinine Increased, Blood Culture Positive, Blood Urea Increased, Bronchospasm, Cough, Dehydration
on Jan 18, 2008 Male patient from UNITED STATES , 63 years of age, weighting 231.5 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Nipent (View Usage). After Nipent was administered, patient had the following side effects: blepharitis, blood bicarbonate increased, blood chloride increased, blood creatinine increased, blood culture positive, blood urea increased, bronchospasm, cough, dehydration. Nipent dosage: 4 Mg/m2 Q12days Iv. During the same period patient was treated with RITUXAN (373 Mg/me Q21days Iv) (View Rituxan Review and Rituxan Label ), CYTOXAN (600 Mg/m2 Q21days Iv) (View Cytoxan Review and Cytoxan Label ), GLUCOPHAGE /00082701/. MFR: NOT SPECIFIED (View Glucophage /00082701/. Mfr: Not Specified Review and Glucophage /00082701/. Mfr: Not Specified Label ), GLUCOTROL (View Glucotrol Review and Glucotrol Label ), AVALIDE. MFR: NOT SPECIFIED (View Avalide. Mfr: Not Specified Review and Avalide. Mfr: Not Specified Label ), TRICOR (View Tricor Review and Tricor Label ), NEURONTIN. MFR: NOT SPECIFIED (View Neurontin. Mfr: Not Specified Review and Neurontin. Mfr: Not Specified Label ), PROCRIT (View Procrit Review and Procrit Label ). Patient was hospitalized.

5613727-0 | Infection, Lymphopenia
on Jan 22, 2008 Male patient from UNITED STATES , 56 years of age, weighting 198.4 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Nipent (View Usage). Patient experienced the following unwanted or unexpected effects: infection (What is infection?), lymphopenia. Nipent dosage: 8.2 Mg Iv. During the same period patient was treated with CYCLOPHOSPHAMIDE (1224 Mg Iv) (View Cyclophosphamide Review and Cyclophosphamide Label ), RITUXIMAB (765 Mg Iv) (View Rituximab Review and Rituximab Label ), BACTRIM (View Bactrim Review and Bactrim Label ). Patient was hospitalized.

5513349-6 | Atrial Fibrillation, Balance Disorder, Dyspnoea, Mental Status Changes, Nausea, Neurological Symptom, Pleural Effusion, Pulmonary Oedema
Patient was taking Nipent (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), balance disorder, dyspnoea, mental status changes, nausea (What is nausea?), neurological symptom, pleural effusion, pulmonary oedema on Oct 25, 2007 from UNITED STATES Additional patient health information: Female patient , 71 years of age, was diagnosed with lymphoma (What is lymphoma?) and. Nipent dosage: 4 Mg Q3w Iv. During the same period patient was treated with VINCRISTINE (1 Mg Q3w Iv) (View Vincristine Review and Vincristine Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), LIPITOR (View Lipitor Review and Lipitor Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), COUMADIN (View Coumadin Review and Coumadin Label ), TOPRAL (View Topral Review and Topral Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), SULFAMETHOXAZOLE AND TRIMETHOPRIM (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ). Patient was hospitalized.

5425852-8 | Activated Partial Thromboplastin Time Prolonged, Bacteria Urine No Organism Observed, Blood Glucose Increased, Blood Urea Increased, Blood Urine Present, Electrolyte Imbalance, Gastritis, Glomerular Filtration Rate Decreased, Haemoglobin Decreased
Adverse event was reported on Aug 16, 2007 by a Female patient taking Nipent (View Usage) (Dosage: 8 Mg Q21days Iv) was diagnosed with non-hodgkin's lymphoma stage iv and. Location: UNITED STATES , 60 years of age, After Nipent was administered, patient had the following side effects: activated partial thromboplastin time prolonged, bacteria urine no organism observed, blood glucose increased, blood urea increased, blood urine present, electrolyte imbalance, gastritis, glomerular filtration rate decreased, haemoglobin decreased. During the same period patient was treated with CYTOXAN (1200 Mg Q21days Iv) (View Cytoxan Review and Cytoxan Label ), RITUXAN (750 Mg Q21days Iv) (View Rituxan Review and Rituxan Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), FLUVASTATIN (View Fluvastatin Review and Fluvastatin Label ). Patient was hospitalized.

5410293-X | Anaemia, Blood Thyroid Stimulating Hormone Increased, Presyncope, Syncope Vasovagal, Thrombocytopenia
on Jul 27, 2007 Female patient from UNITED STATES , 62 years of age, weighting 179.9 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Nipent (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, blood thyroid stimulating hormone increased, presyncope, syncope vasovagal, thrombocytopenia. Nipent dosage: 4 Mg/m2 Q21days. During the same period patient was treated with CYCLOPHOSPHAMID. MFR: NOT SPECIFIED (600 Mg/m2 Q21 Days) (View Cyclophosphamid. Mfr: Not Specified Review and Cyclophosphamid. Mfr: Not Specified Label ), RITUXAN (375 Mg/m2 Q21days) (View Rituxan Review and Rituxan Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), ALLEGRA (View Allegra Review and Allegra Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ). Patient was hospitalized.

5404269-6 | Gastritis, Sepsis
on Jul 24, 2007 Female patient from UNITED STATES , 60 years of age, was diagnosed with non-hodgkin's lymphoma stage iv and was treated with Nipent (View Usage). Patient had the following side effects: gastritis, sepsis (What is sepsis?). Nipent dosage: 8 Mg Q21days Iv. During the same period patient was treated with CYTOXAN (1200 Mg Q21days Iv) (View Cytoxan Review and Cytoxan Label ), RITUXAN (750 Mg Q21days Iv) (View Rituxan Review and Rituxan Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), FLUVASTATIN (View Fluvastatin Review and Fluvastatin Label ). Patient was hospitalized.

5388450-0 | Bronchitis, Interstitial Lung Disease
Patient was taking Nipent (View Usage). After Nipent was administered, patient had the following side effects: bronchitis (What is bronchitis?), interstitial lung disease on Jun 27, 2007 from FRANCE Additional patient health information: Female patient , 52 years of age, weighting 101.4 lb, was diagnosed with chronic lymphocytic leukaemia and. Nipent dosage: 6 Mg Per _ Cycle Iv. During the same period patient was treated with ENDOXAN. MFR: NOT SPECIFIED (910 Mg Per_ Cycle Iv) (View Endoxan. Mfr: Not Specified Review and Endoxan. Mfr: Not Specified Label ), MABTHERA. MFR: NOT SPECIFIED (570 Mg Per_cycle Iv) (View Mabthera. Mfr: Not Specified Review and Mabthera. Mfr: Not Specified Label ), BACTRIM (View Bactrim Review and Bactrim Label ), SELITREX (View Selitrex Review and Selitrex Label ). Patient was hospitalized.

5383658-2 | Blood Pressure Decreased, Diarrhoea, Immunoglobulins Decreased, Pain, Pneumonia, Pulmonary Embolism, Sepsis, Sinusitis, Skin Discolouration
Adverse event was reported on Jun 29, 2007 by a Female patient taking Nipent (View Usage) (Dosage: 7.56 Mg Once Iv) was diagnosed with chronic lymphocytic leukaemia and. Location: UNITED STATES , 54 years of age, weighting 162.0 lb, Patient experienced the following unwanted or unexpected effects: blood pressure decreased, diarrhoea, immunoglobulins decreased, pain (What is pain?), pneumonia (What is pneumonia?), pulmonary embolism (What is pulmonary embolism?), sepsis (What is sepsis?), sinusitis (What is sinusitis?), skin discolouration. During the same period patient was treated with CYTOXAN (1134 Mg Once Iv) (View Cytoxan Review and Cytoxan Label ), RITUXAN (100 Mg Once Iv) (View Rituxan Review and Rituxan Label ). Patient was hospitalized.

5330258-6 | Bacterial Infection, Blood Immunoglobulin G Decreased, Furuncle, Lobar Pneumonia, Metabolic Disorder, Neutropenic Infection, Renal Failure Acute, Sepsis, Urinary Tract Infection
on May 03, 2007 Male patient from UNITED STATES , 52 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Nipent (View Usage). Patient had the following side effects: bacterial infection (What is bacterial infection?), blood immunoglobulin g decreased, furuncle, lobar pneumonia, metabolic disorder (What is metabolic disorder?), neutropenic infection, renal failure acute, sepsis (What is sepsis?), urinary tract infection (What is urinary tract infection?). Nipent dosage: 8.52 Mg Q3w. During the same period patient was treated with CYTOXAN (1270 Mg Q3w) (View Cytoxan Review and Cytoxan Label ), RITUXAN (798 Mg Q3w) (View Rituxan Review and Rituxan Label ), NORVASC (View Norvasc Review and Norvasc Label ), DOXEPIN HCL (View Doxepin Hcl Review and Doxepin Hcl Label ), HYDROXYZINE HYDROCHLORIDE (View Hydroxyzine Hydrochloride Review and Hydroxyzine Hydrochloride Label ), IMMUNE GLOBULIN INTRAVENOUS (HUMAN) (View Immune Globulin Intravenous (human) Review and Immune Globulin Intravenous (human) Label ). Patient was hospitalized.

5307705-9 | Atrial Fibrillation, Balance Disorder, Mental Status Changes, Nausea, Neurological Symptom, Pleural Effusion, Pulmonary Oedema
on Apr 02, 2007 Female patient from UNITED STATES , 71 years of age, was diagnosed with lymphoma (What is lymphoma?) and was treated with Nipent (View Usage). After Nipent was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), balance disorder, mental status changes, nausea (What is nausea?), neurological symptom, pleural effusion, pulmonary oedema. Nipent dosage: 4 Mg Q3w Iv. During the same period patient was treated with VINCRISTINE (1 Mg Q3w Iv) (View Vincristine Review and Vincristine Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), LIPITOR /01326101/. MFR: NOT SPECIFIED (View Lipitor /01326101/. Mfr: Not Specified Review and Lipitor /01326101/. Mfr: Not Specified Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), COUMADIN. MFR: NOT SPECIFIED (View Coumadin. Mfr: Not Specified Review and Coumadin. Mfr: Not Specified Label ), TOPRAL. MFR: NOT SPECIFIED (View Topral. Mfr: Not Specified Review and Topral. Mfr: Not Specified Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), BACTRIM DS (View Bactrim Ds Review and Bactrim Ds Label ). Patient was hospitalized.

5206152-8 | Atrial Fibrillation, Balance Disorder, Dyspnoea, Mental Status Changes, Nausea, Neurological Symptom, Pulmonary Oedema
Patient was taking Nipent (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), balance disorder, dyspnoea, mental status changes, nausea (What is nausea?), neurological symptom, pulmonary oedema on Dec 28, 2006 from UNITED STATES Additional patient health information: Female patient , 71 years of age, was diagnosed with lymphoma (What is lymphoma?) and. Nipent dosage: . During the same period patient was treated with VINCRISTINE (View Vincristine Review and Vincristine Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ).

5173268-4 | Asthenia, Failure To Thrive, Nausea
Adverse event was reported on Nov 20, 2006 by a Female patient taking Nipent (View Usage) (Dosage: 1.7143 Mg/m2 (4 Mg/m2,qd X 3), Intravenous) was diagnosed with stem cell transplant and. Location: UNITED STATES , 67 years of age, weighting 163.8 lb, Patient had the following side effects: asthenia, failure to thrive, nausea (What is nausea?).

5168857-7 | Abdominal Pain Upper, Anxiety, Balance Disorder, Cerebrovascular Accident, Chills, Coma, Convulsion, Depressed Level Of Consciousness, Dyspnoea
on Dec 05, 2006 Female patient from UNITED STATES , 71 years of age, weighting 150.0 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Nipent (View Usage). After Nipent was administered, patient had the following side effects: abdominal pain upper, anxiety (What is anxiety?), balance disorder, cerebrovascular accident, chills, coma, convulsion, depressed level of consciousness, dyspnoea. Nipent dosage: Every 3 Wks X 3 Iv Drip. Patient was hospitalized.

5164715-2 | Pancytopenia, Stem Cell Transplant, Transplant Rejection
on Nov 10, 2006 Female patient from UNITED STATES , 36 years of age, weighting 172.4 lb, was diagnosed with prophylaxis against graft versus host disease and was treated with Nipent (View Usage). Patient experienced the following unwanted or unexpected effects: pancytopenia, stem cell transplant, transplant rejection. Nipent dosage: (1.5 Mg/m2, X 4), Intravenous.

5148860-3 | Cardio-respiratory Arrest, Diarrhoea, Hypotension, Hypoxia, Nausea, Pulmonary Embolism, Sepsis
Patient was taking Nipent (View Usage). Patient had the following side effects: cardio-respiratory arrest, diarrhoea, hypotension, hypoxia, nausea (What is nausea?), pulmonary embolism (What is pulmonary embolism?), sepsis (What is sepsis?) on Oct 09, 2006 from UNITED STATES Additional patient health information: Female patient , 64 years of age, weighting 220.0 lb, was diagnosed with chronic lymphocytic leukaemia and. Nipent dosage: 2 Mg/m2 (2 Mg/m2, Q 21 Days), Ivpb. During the same period patient was treated with RITUXAN (375 Mg/m2 (375 Mg/m2, Q 21 Days), Ivpb) (View Rituxan Review and Rituxan Label ), CYCLOPHOSPHAMIDE (600 Mg/m2 (600 Mg/m2, Q 21 Days), Ivpb) (View Cyclophosphamide Review and Cyclophosphamide Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), BENADRYL (View Benadryl Review and Benadryl Label ), CELEBREX (View Celebrex Review and Celebrex Label ), ALDOMET (View Aldomet Review and Aldomet Label ), LASIX (View Lasix Review and Lasix Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ). Patient was hospitalized.

5128247-X | Angiopathy, Basedow's Disease, Erythema Nodosum, Goitre, Lung Infiltration, Palpitations, Sarcoidosis, Weight Decreased
Adverse event was reported on Oct 04, 2006 by a Male patient taking Nipent (View Usage) (Dosage: -- (tot 9 Cyc; 1 Cyc/2 Wks), Intravenous) was diagnosed with hairy cell leukaemia and. Location: FRANCE , 65 years of age, After Nipent was administered, patient had the following side effects: angiopathy, basedow's disease, erythema nodosum, goitre, lung infiltration, palpitations, sarcoidosis, weight decreased. Patient was hospitalized.

5113831-X | Bronchopulmonary Aspergillosis
on Sep 14, 2006 Male patient from UNITED STATES , 57 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Nipent (View Usage). Patient experienced the following unwanted or unexpected effects: bronchopulmonary aspergillosis. Nipent dosage: (6 Cycles). During the same period patient was treated with CYCLOPHOSPHAMIDE ((6 (cycles)) (View Cyclophosphamide Review and Cyclophosphamide Label ), RITUXIMAB (RITUXIMAB) (RITUXIMAB) ((6 Cycles)) (View Rituximab (rituximab) (rituximab) Review and Rituximab (rituximab) (rituximab) Label ), ACYCLOVIR (ACICLOVIR) (ACICLOVIR) (View Acyclovir (aciclovir) (aciclovir) Review and Acyclovir (aciclovir) (aciclovir) Label ), ALLOPURINOL (ALLOPURINOL) (ALLOPURINOL) (View Allopurinol (allopurinol) (allopurinol) Review and Allopurinol (allopurinol) (allopurinol) Label ), SULFAMETHOXAZOLE/TRIMETHROPRIM (SULFAMETHOXAZOLE, TRIMETHOPRIM) (SULFA (View Sulfamethoxazole/trimethroprim (sulfamethoxazole, Trimethoprim) (sulfa Review and Sulfamethoxazole/trimethroprim (sulfamethoxazole, Trimethoprim) (sulfa Label ). Patient was hospitalized.

5113825-4 | Renal Failure, Tumour Lysis Syndrome
on Sep 14, 2006 Male patient from UNITED STATES , 70 years of age, weighting 198.4 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Nipent (View Usage). Patient had the following side effects: renal failure, tumour lysis syndrome. Nipent dosage: 0.1905 Mg/m2 (4 Mg/m2, 1 In 21 D), Intravenous. During the same period patient was treated with RITUXAN ((375 Mg/m2), Intravenous) (View Rituxan Review and Rituxan Label ), CYCLOPHOSPHAMIDE (28.5714 Mg/m2 (600 Mg/m2, 1 In 21 D), Intravenous) (View Cyclophosphamide Review and Cyclophosphamide Label ), ACYCLORVIR (ACICLOVIR (ACICLOVIR) (View Acyclorvir (aciclovir (aciclovir) Review and Acyclorvir (aciclovir (aciclovir) Label ), ALLOPURINOL (ALLOPURINOL) (ALLOPURINOL) (View Allopurinol (allopurinol) (allopurinol) Review and Allopurinol (allopurinol) (allopurinol) Label ), BACTRIM (SULFAMETHOXAZOLE, TRIMETHOPRIM) (SULFAMETHOXAZOLE, TRIMETHOPR (View Bactrim (sulfamethoxazole, Trimethoprim) (sulfamethoxazole, Trimethopr Review and Bactrim (sulfamethoxazole, Trimethoprim) (sulfamethoxazole, Trimethopr Label ), LASIC (FUROSEMIDE) (FUROSEMIDE) (View Lasic (furosemide) (furosemide) Review and Lasic (furosemide) (furosemide) Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

5113808-4 | Eye Swelling, Oedema Peripheral, Swollen Tongue
Patient was taking Nipent (View Usage). After Nipent was administered, patient had the following side effects: eye swelling, oedema peripheral, swollen tongue on Sep 06, 2006 from UNITED STATES Additional patient health information: Male patient , child 6 years of age, weighting 41.45 lb, was diagnosed with graft versus host disease and. Nipent dosage: 0.1071 Mg (1.5 Mg, Every 2 Weeks), Intravenous. During the same period patient was treated with PREDNISONE (PREDNISONE) (PREDNISONE) (View Prednisone (prednisone) (prednisone) Review and Prednisone (prednisone) (prednisone) Label ), TACRO (View Tacro Review and Tacro Label ), SEPTRA (SULFAMETHOXAZOLE, TRIMETHOPRIM) (SULFAMETHOXAZOLE, TRIMETHOPRI (View Septra (sulfamethoxazole, Trimethoprim) (sulfamethoxazole, Trimethopri Review and Septra (sulfamethoxazole, Trimethoprim) (sulfamethoxazole, Trimethopri Label ), HYDROXIZME (View Hydroxizme Review and Hydroxizme Label ), CELLCEPT (MYCOPHENOLATE MOFETIL) (MYCOPHENOLATE MOFETIL) (View Cellcept (mycophenolate Mofetil) (mycophenolate Mofetil) Review and Cellcept (mycophenolate Mofetil) (mycophenolate Mofetil) Label ), CARAFATE (SUCRALFATE) (SUCRALFATE) (View Carafate (sucralfate) (sucralfate) Review and Carafate (sucralfate) (sucralfate) Label ), ZOFRAN (ONDANSETRON HYDROHCLORIDE) (ONDANSETRON HYDROCHLORIDE) (View Zofran (ondansetron Hydrohcloride) (ondansetron Hydrochloride) Review and Zofran (ondansetron Hydrohcloride) (ondansetron Hydrochloride) Label ), MAGNESIUM (MAGNESIUM) (TABLETS) (MAGNESIUM) (View Magnesium (magnesium) (tablets) (magnesium) Review and Magnesium (magnesium) (tablets) (magnesium) Label ). Patient was hospitalized.

5105087-9 | Abdominal Pain, Epstein-barr Virus Infection, Lymphoma, Lymphoproliferative Disorder, Nausea
Adverse event was reported on Aug 28, 2006 by a Male patient taking Nipent (View Usage) (Dosage: Every 3 Weeks) was diagnosed with graft versus host disease and. Location: UNITED STATES , 20 years of age, weighting 149.9 lb, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), epstein-barr virus infection, lymphoma (What is lymphoma?), lymphoproliferative disorder, nausea (What is nausea?). During the same period patient was treated with PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), VALGANCYCLOVIR (View Valgancyclovir Review and Valgancyclovir Label ), VORICONAZOLE (VORICONAZOLE) (View Voriconazole (voriconazole) Review and Voriconazole (voriconazole) Label ), PEN VK (PHENOXYMETHYLPENICILLIN POTASSIUM) (View Pen Vk (phenoxymethylpenicillin Potassium) Review and Pen Vk (phenoxymethylpenicillin Potassium) Label ), PEPCID (View Pepcid Review and Pepcid Label ), BACTRIM DS (View Bactrim Ds Review and Bactrim Ds Label ), INSULIN (INSULIN) (View Insulin (insulin) Review and Insulin (insulin) Label ).

5082752-3 | Anorexia, Blood Glucose Increased, Blood Ph Decreased, Bradycardia, Bundle Branch Block, Cardiogenic Shock, Chest Pain, Dyspnoea, Hypoxia
on Aug 01, 2006 Male patient from UNITED STATES , 65 years of age, weighting 211.6 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Nipent (View Usage). Patient had the following side effects: anorexia, blood glucose increased, blood ph decreased, bradycardia, bundle branch block, cardiogenic shock, chest pain (What is chest pain?), dyspnoea, hypoxia. Nipent dosage: 0.2986 Mg (8.36 Mg, Q 4 Wks), Intravenous. During the same period patient was treated with CYTOXAN (44.7857 Mg (1254 Mg, Q 4wks), Intravenous) (View Cytoxan Review and Cytoxan Label ), ALOXI (PALONOSETRON HYDROCHLORIDE) (PALONOSETRON HYDROCHLORIDE) (View Aloxi (palonosetron Hydrochloride) (palonosetron Hydrochloride) Review and Aloxi (palonosetron Hydrochloride) (palonosetron Hydrochloride) Label ), LIPITOR (View Lipitor Review and Lipitor Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), TOPROL XL (METOPROLOL SUCCINATE) (METOPROLOL SUCCINATE) (View Toprol Xl (metoprolol Succinate) (metoprolol Succinate) Review and Toprol Xl (metoprolol Succinate) (metoprolol Succinate) Label ), LASIX (View Lasix Review and Lasix Label ), ECOTRIN (ACETYLSALICYLIC ACID) (ACETYLSALICYLIC ACID) (View Ecotrin (acetylsalicylic Acid) (acetylsalicylic Acid) Review and Ecotrin (acetylsalicylic Acid) (acetylsalicylic Acid) Label ), MULTIVITAMIN (View Multivitamin Review and Multivitamin Label ). Patient was hospitalized.

5074541-0 | Chest Pain, Pericardial Effusion, Pulmonary Hypertension
on Jul 24, 2006 Female patient from PUERTO RICO , 74 years of age, weighting 171.0 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Nipent (View Usage). After Nipent was administered, patient had the following side effects: chest pain (What is chest pain?), pericardial effusion, pulmonary hypertension (What is pulmonary hypertension?). Nipent dosage: -- (1.25 Mg/m2, Days 2, 3, Every 21 Days), Intravenous. During the same period patient was treated with RITUXIMAB (RITUXIMAB) (RITUXIMAB) (-- (375 Mg/m2, Day One Every 21 Days), Intravenous) (View Rituximab (rituximab) (rituximab) Review and Rituximab (rituximab) (rituximab) Label ), GEMCITABINE (GEMCITABINE) (GEMCITABINE) (-- (750 Mg/m2, Day 2 Every 21 Days)) (View Gemcitabine (gemcitabine) (gemcitabine) Review and Gemcitabine (gemcitabine) (gemcitabine) Label ), NEUPOGEN (-- (300 Mcg, Daily X 7-10 Days Starting On Day 5 Q21d)) (View Neupogen Review and Neupogen Label ).

5074479-9 | Bacteria Blood Identified, Corynebacterium Infection, Hypersensitivity, Hypotension, Multi-organ Failure, Pyrexia, Sepsis, Staphylococcal Infection
Patient was taking Nipent (View Usage). Patient experienced the following unwanted or unexpected effects: bacteria blood identified, corynebacterium infection, hypersensitivity, hypotension, multi-organ failure, pyrexia, sepsis (What is sepsis?), staphylococcal infection (What is staphylococcal infection?) on Jul 20, 2006 from UNITED STATES Additional patient health information: Male patient , 61 years of age, weighting 200.0 lb, was diagnosed with chronic lymphocytic leukaemia and. Nipent dosage: -- (4 Mg/m2, Cld1, C2-6d1), Intravenous. During the same period patient was treated with RITUXIMAB (RITUXIMAB) (RITUXIMAB) (-- (100 Mg, C1d1), Intravenous) (View Rituximab (rituximab) (rituximab) Review and Rituximab (rituximab) (rituximab) Label ), CYCLOPHOSPHAMIDE (-- (600 Mg/m2, C1d1, Cycles 2-6, Day 1), Intravenous) (View Cyclophosphamide Review and Cyclophosphamide Label ). Patient was hospitalized.

5062395-8 | Atelectasis, Atrial Fibrillation, Supraventricular Tachycardia
Adverse event was reported on Jul 12, 2006 by a Male patient taking Nipent (View Usage) (Dosage: 0.2619 Mg (5.5 Mg, On Day 1 Of 21 Day Cycle)) was diagnosed with chronic lymphocytic leukaemia and. Location: UNITED STATES , 82 years of age, weighting 160.0 lb, Patient had the following side effects: atelectasis, atrial fibrillation (What is atrial fibrillation?), supraventricular tachycardia. During the same period patient was treated with RITUXAN (32.5238 Mg (683 Mg, On Day 1 Of 21 Day Cycle)) (View Rituxan Review and Rituxan Label ), CYTOXAN (52 Mg (1092 Mg, On Day 1 Of 21 Day Cycle)) (View Cytoxan Review and Cytoxan Label ), ALOXI (PALONOSETRON HYDROCHLORIDE) (PALONOSETRON HYDROCHLORIDE) (View Aloxi (palonosetron Hydrochloride) (palonosetron Hydrochloride) Review and Aloxi (palonosetron Hydrochloride) (palonosetron Hydrochloride) Label ), DECADRON (View Decadron Review and Decadron Label ), ARANESP (View Aranesp Review and Aranesp Label ), HEPARIN (View Heparin Review and Heparin Label ), NAPROXEN (View Naproxen Review and Naproxen Label ), FUROSEMIDE (FUROSEMIDE) (FUROSEMIDE) (View Furosemide (furosemide) (furosemide) Review and Furosemide (furosemide) (furosemide) Label ). Patient was hospitalized.

5038658-9 | Blood Culture Positive, Bronchopulmonary Aspergillosis, Chest Pain, Cough, Cytomegalovirus Test Positive, Fungal Infection, Hepatomegaly, Hyperpyrexia, Jaundice
on Jun 07, 2006 Male patient from ITALY , 39 years of age, was diagnosed with t-cell lymphoma and was treated with Nipent (View Usage). After Nipent was administered, patient had the following side effects: blood culture positive, bronchopulmonary aspergillosis, chest pain (What is chest pain?), cough, cytomegalovirus test positive, fungal infection (What is fungal infection?), hepatomegaly, hyperpyrexia, jaundice (What is jaundice?). Nipent dosage: 5 Mg/m2, Day 1-3.

5038183-5 | Anorexia, Blood Chloride Decreased, Blood Glucose Increased, Blood Ph Decreased, Blood Potassium Increased, Blood Sodium Decreased, Bradycardia, Bundle Branch Block, Chest Discomfort
on Jun 16, 2006 Male patient from UNITED STATES , 65 years of age, weighting 211.6 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Nipent (View Usage). Patient experienced the following unwanted or unexpected effects: anorexia, blood chloride decreased, blood glucose increased, blood ph decreased, blood potassium increased, blood sodium decreased, bradycardia, bundle branch block, chest discomfort. Nipent dosage: 8.36 Mg (8.36 Mg, Qd), Intravenous. During the same period patient was treated with CYTOXAN (1254 Mg (1254 Mg, Qd), Intravenous) (View Cytoxan Review and Cytoxan Label ), ALOXI (PALONOSETRON HYDROCHLORIDE (PALONOSETRON HYDROCHLORIDE) (View Aloxi (palonosetron Hydrochloride (palonosetron Hydrochloride) Review and Aloxi (palonosetron Hydrochloride (palonosetron Hydrochloride) Label ), LIPITOR (View Lipitor Review and Lipitor Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), TOPROL XL (METOPROLOL SUCCINATE) (METOPROLOL SUCCINATE) (View Toprol Xl (metoprolol Succinate) (metoprolol Succinate) Review and Toprol Xl (metoprolol Succinate) (metoprolol Succinate) Label ), LASIX (View Lasix Review and Lasix Label ), ECOTRIN (ACETYLSALICYLIC ACID) (ACETYLSALICYLIC ACID) (View Ecotrin (acetylsalicylic Acid) (acetylsalicylic Acid) Review and Ecotrin (acetylsalicylic Acid) (acetylsalicylic Acid) Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ). Patient was hospitalized.

5038182-3 | Blood Potassium Increased, Blood Uric Acid Increased, Dialysis, Dyspnoea, Metabolic Acidosis, Renal Failure Acute, Sepsis, Tumour Lysis Syndrome
Patient was taking Nipent (View Usage). Patient had the following side effects: blood potassium increased, blood uric acid increased, dialysis (What is dialysis?), dyspnoea, metabolic acidosis, renal failure acute, sepsis (What is sepsis?), tumour lysis syndrome on Jun 15, 2006 from UNITED STATES Additional patient health information: Female patient , 64 years of age, was diagnosed with chronic lymphocytic leukaemia and. Nipent dosage: . During the same period patient was treated with RITUXAN (View Rituxan Review and Rituxan Label ), CYTOXAN (View Cytoxan Review and Cytoxan Label ). Patient was hospitalized.

5028057-8 | Blood Creatinine Increased, Feeling Abnormal, Organ Failure
Adverse event was reported on May 26, 2006 by a Female patient taking Nipent (View Usage) (Dosage: ) was diagnosed with non-hodgkin's lymphoma and. Location: UNITED STATES , 43 years of age, After Nipent was administered, patient had the following side effects: blood creatinine increased, feeling abnormal, organ failure. During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), RITUXAN (View Rituxan Review and Rituxan Label ).

4994285-0 | Colon Cancer
on Mar 14, 2003 Female patient from FRANCE , 70 years of age, was diagnosed with hairy cell leukaemia and was treated with Nipent (View Usage). Patient experienced the following unwanted or unexpected effects: colon cancer. Nipent dosage: 4 Mg/m^2 (1 X Per 2 Wk), Intravenous Bolus.

4994279-5 | Multiple Myeloma
on Mar 13, 2003 Female patient from FRANCE , 59 years of age, was diagnosed with hairy cell leukaemia and was treated with Nipent (View Usage). Patient had the following side effects: multiple myeloma (What is multiple myeloma?). Nipent dosage: 4 Mg/m^2 (1 X Per 2 Wk), Intravenous. Patient was hospitalized.

4994277-1 | Adult T-cell Lymphoma/leukaemia
Patient was taking Nipent (View Usage). After Nipent was administered, patient had the following side effects: adult t-cell lymphoma/leukaemia on Mar 14, 2003 from FRANCE Additional patient health information: Female patient , 71 years of age, was diagnosed with hairy cell leukaemia and. Nipent dosage: (4 Mg/m2, 1 X Per 2 Wk), Intravenous.

4994272-2 | Diffuse Large B-cell Lymphoma
Adverse event was reported on Mar 13, 2003 by a Female patient taking Nipent (View Usage) (Dosage: 4 Mg/m^2 (1 X Per 2 Wk)) was diagnosed with hairy cell leukaemia and. Location: FRANCE , 67 years of age, Patient experienced the following unwanted or unexpected effects: diffuse large b-cell lymphoma. Patient was hospitalized.

4994270-9 | Diffuse Large B-cell Lymphoma
on Mar 13, 2003 Female patient from FRANCE , 50 years of age, was diagnosed with hairy cell leukaemia and was treated with Nipent (View Usage). Patient had the following side effects: diffuse large b-cell lymphoma. Nipent dosage: 4 Mg/m^2 (1 X Per 2 Wk). Patient was hospitalized.

4994268-0 | Mantle Cell Lymphoma
on Mar 14, 2003 Female patient from FRANCE , 74 years of age, was diagnosed with hairy cell leukaemia and was treated with Nipent (View Usage). After Nipent was administered, patient had the following side effects: mantle cell lymphoma. Nipent dosage: 4 Mg/m^2 (1 X Per 2 Wk), Intravenous. Patient was hospitalized.

4994266-7 | Breast Cancer
Patient was taking Nipent (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?) on Mar 14, 2003 from FRANCE Additional patient health information: Female patient , 67 years of age, was diagnosed with hairy cell leukaemia and. Nipent dosage: 4 Mg/m^2 (4 Mg/m2, 1 X Per 2 Wk), Intravenous.

4994206-0 | Oesophageal Carcinoma
Adverse event was reported on Mar 14, 2003 by a Female patient taking Nipent (View Usage) (Dosage: 4 Mg/m2, 1x Per 2 Wk, Intravenous) was diagnosed with hairy cell leukaemia and. Location: FRANCE , 70 years of age, Patient had the following side effects: oesophageal carcinoma.

4994204-7 | Prostate Cancer
on Mar 13, 2003 Male patient from FRANCE , 67 years of age, was diagnosed with hairy cell leukaemia and was treated with Nipent (View Usage). After Nipent was administered, patient had the following side effects: prostate cancer (What is prostate cancer?). Nipent dosage: 4 Mg/m^2 (1 X Per 2 Wk), Intravenous Bolus. Patient was hospitalized.

4994202-3 | Prostate Cancer
on Mar 13, 2003 Male patient from FRANCE , 68 years of age, was diagnosed with hairy cell leukaemia and was treated with Nipent (View Usage). Patient experienced the following unwanted or unexpected effects: prostate cancer (What is prostate cancer?). Nipent dosage: 4 Mg/m2/day (every Two Weeks). Patient was hospitalized.

4994197-2 | Prostate Cancer
Patient was taking Nipent (View Usage). Patient had the following side effects: prostate cancer (What is prostate cancer?) on Mar 13, 2003 from FRANCE Additional patient health information: Male patient , 68 years of age, was diagnosed with hairy cell leukaemia and. Nipent dosage: 4 Mg/m2/day (every 2 Weeks). Patient was hospitalized.